Clinical Trials Logo

Filter by:
NCT ID: NCT02234310 Completed - Hemophilia B Clinical Trials

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

PUPs B-LONG
Start date: November 13, 2014
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to evaluate the safety of recombinant coagulation factor IX Fc fusion protein (rFIXFc, BIIB029) in previously untreated patients (PUPs) with severe hemophilia B. Secondary objectives were to evaluate the efficacy of rFIXFc in the prevention and treatment of bleeding episodes in PUPs, and to evaluate rFIXFc consumption for prevention and treatment of bleeding episodes in PUPs.

NCT ID: NCT02234141 Completed - Clinical trials for Pulmonary Arterial Hypertension

Selonsertib in Adults With Pulmonary Arterial Hypertension

ARROW
Start date: November 2014
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effect of selonsertib (GS-4997) on pulmonary vascular resistance (PVR), as measured by right heart catheterization (RHC) in adults with pulmonary arterial hypertension (PAH). The study will consist of a 24-week placebo-controlled treatment period and a long-term selonsertib treatment period. Participants completing the 24-week placebo-controlled period will be eligible to receive active treatment with selonsertib in the long-term treatment period.

NCT ID: NCT02234050 Completed - Clinical trials for Recurrent High Grade Meningioma

Trabectedin for Recurrent Grade II/III Meningioma

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to collect data on activity, toxicity and quality of life of trabectedin therapy in patients with recurrent high-grade meningioma.

NCT ID: NCT02232061 Completed - Multiple Sclerosis Clinical Trials

Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks

Start date: September 29, 2014
Phase: Phase 4
Study type: Interventional

This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events

NCT ID: NCT02231593 Completed - Acromegaly Clinical Trials

SAGIT for Classification of Patients With Acromegaly in Clinical Practice

SAGIT Pilot
Start date: February 2013
Phase:
Study type: Observational

The purpose of this pilot study is to test SAGIT (Signs and symptoms - Associated comorbidities - GH concentration level - IGF-1 - Tumour). SAGIT is a Clinician-Reported Outcomes (ClinROs) tool developed to describe patients with acromegaly. This study will determine the potential use of a finalised operational version for patient classification in clinical practice and studies. In addition, this study intends to carry out a qualitative evaluation of the acceptability of SAGIT by the practicing endocrinologist in terms of relevance, ease of use, applicability and usefulness of the tool in practice.

NCT ID: NCT02231554 Completed - Clinical trials for Chronic Low Back Pain

Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study study is to determine whether the Feldenkrais method is effective on pain control, functional recovery and quality of life in patients with chronic low back pain by comparing it with a Back School program.

NCT ID: NCT02231541 Completed - Fibromyalgia Clinical Trials

Very Low Frequency Magnetic Fields in the Treatment of Fibromyalgia

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effectiveness of treatment with very low frequency electromagnetic fields on the reduction of pain in patients with fibromylgia, disease presenting with widespread musculoskeletal pain usually associated with other symptoms such as stiffness, fatigue, sleep disturbances, depression, anxiety.

NCT ID: NCT02230969 Completed - Clinical trials for Relapsing Forms of Multiple Sclerosis

Plegridy Observational Program

POP
Start date: November 12, 2014
Phase:
Study type: Observational

The primary objectives of the study are to determine the incidence of serious adverse events (SAEs) in participants with relapsing forms of multiple sclerosis (MS) in routine clinical practice and to assess the overall long-term clinical effectiveness of Plegridy in participants with relapsing forms of MS in routine clinical practice. The secondary objectives of this study in this study population are to describe Plegridy prescription and utilization adherence patterns in routine clinical practice; to assess the specific long-term clinical effectiveness of Plegridy in participants with relapsing forms of MS in routine clinical practice; to monitor the safety and tolerability of Plegridy in routine clinical practice by assessing the incidence of adverse events (AEs) of flu-like symptoms (FLS), injection site reactions (ISRs), and AEs (including laboratory abnormalities) leading to treatment discontinuation; to assess the effect of FLS on participant-reported effectiveness of, and satisfaction with, prophylactic management using a FLS-Visual Analog Scale (FLS-VAS); to evaluate the change in health-related quality of life (HRQoL), FLS, FLS-VAS, healthcare resource consumption, and treatment adherence over time.

NCT ID: NCT02230397 Completed - Healthy Clinical Trials

Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream

Start date: October 2013
Phase: Phase 3
Study type: Interventional

Aim of the study was to evaluate clinically and by non-invasive instrumental evaluations the "revitalizing" activity of a face cream applied twice a day, morning and evening, for an uninterrupted period of 8 weeks, by healthy female volunteers aged 45-55 years with face ritidosis and women aged 55-65 years not habitual user of antiage-creams. The study foresaw the comparison within subjects of the study product versus placebo (half face method). It was also aim of this study to evaluate products efficacy and cosmetic acceptability by the volunteers and tolerance both by investigator and volunteers.

NCT ID: NCT02229591 Completed - Clinical trials for Postoperative Respiratory Complications

Expiratory Flow Limitation and Postoperative Complications

Start date: January 2013
Phase: N/A
Study type: Observational

Expiratory flow limitation (EFL) occurs when flow ceases to increase with increasing expiratory effort. In any circumstances EFL predisposes to pulmonary dynamic hyperinflation and its unfavorable effects such as increased elastic work of breathing, inspiratory muscles dysfunction, and progressive neuroventilatory dissociation, leading to reduced exercise tolerance, marked breathlessness during effort, and severe chronic dyspnea. Our hypothesis is that EFL should affect post operative outcomes like incidence of pulmonary complication and length of stay in hospital